136 related articles for article (PubMed ID: 18406239)
21. Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome.
Wickenheisser JK; Nelson-Degrave VL; McAllister JM
J Clin Endocrinol Metab; 2005 Mar; 90(3):1720-7. PubMed ID: 15598676
[TBL] [Abstract][Full Text] [Related]
22. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens.
Nestler JE; Jakubowicz DJ
J Clin Endocrinol Metab; 1997 Dec; 82(12):4075-9. PubMed ID: 9398716
[TBL] [Abstract][Full Text] [Related]
23. Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome.
Munir I; Yen HW; Baruth T; Tarkowski R; Azziz R; Magoffin DA; Jakimiuk AJ
J Clin Endocrinol Metab; 2005 Aug; 90(8):4852-7. PubMed ID: 15886251
[TBL] [Abstract][Full Text] [Related]
24. Molecular evolution of adrenarche: structural and functional analysis of p450c17 from four primate species.
Arlt W; Martens JW; Song M; Wang JT; Auchus RJ; Miller WL
Endocrinology; 2002 Dec; 143(12):4665-72. PubMed ID: 12446594
[TBL] [Abstract][Full Text] [Related]
25. Impact of differential P450c17 phosphorylation by cAMP stimulation and by starvation conditions on enzyme activities and androgen production in NCI-H295R cells.
Kempná P; Hirsch A; Hofer G; Mullis PE; Flück CE
Endocrinology; 2010 Aug; 151(8):3686-96. PubMed ID: 20534731
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation.
Mesiano S; Katz SL; Lee JY; Jaffe RB
J Clin Endocrinol Metab; 1997 May; 82(5):1390-6. PubMed ID: 9141522
[TBL] [Abstract][Full Text] [Related]
27. P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5.
Geller DH; Auchus RJ; Miller WL
Mol Endocrinol; 1999 Jan; 13(1):167-75. PubMed ID: 9892022
[TBL] [Abstract][Full Text] [Related]
28. 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.
Jakubowicz DJ; Nestler JE
J Clin Endocrinol Metab; 1997 Feb; 82(2):556-60. PubMed ID: 9024253
[TBL] [Abstract][Full Text] [Related]
29. Disorders of androgen synthesis--from cholesterol to dehydroepiandrosterone.
Miller WL
Med Princ Pract; 2005; 14 Suppl 1():58-68. PubMed ID: 16103714
[TBL] [Abstract][Full Text] [Related]
30. Insulin resistance in prepubertal African-American and Hispanic girls with premature adrenarche: a risk factor for polycystic ovary syndrome.
DiMartino-Nardi J
Trends Endocrinol Metab; 1998 Feb; 9(2):78-82. PubMed ID: 18406246
[TBL] [Abstract][Full Text] [Related]
31. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies.
Xita N; Tsatsoulis A
J Clin Endocrinol Metab; 2006 May; 91(5):1660-6. PubMed ID: 16522691
[TBL] [Abstract][Full Text] [Related]
32. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.
Dunaif A; Xia J; Book CB; Schenker E; Tang Z
J Clin Invest; 1995 Aug; 96(2):801-10. PubMed ID: 7635975
[TBL] [Abstract][Full Text] [Related]
33. A Homodimer Model Can Resolve the Conundrum as to How Cytochrome P450 Oxidoreductase and Cytochrome b5 Compete for the Same Binding Site on Cytochrome P450c17.
Holien JK; Parker MW; Conley AJ; Corbin CJ; Rodgers RJ; Martin LL
Curr Protein Pept Sci; 2017; 18(5):515-521. PubMed ID: 28000554
[TBL] [Abstract][Full Text] [Related]
34. Pitfalls in characterizing P450c17 mutations associated with isolated 17,20-lyase deficiency.
Gupta MK; Geller DH; Auchus RJ
J Clin Endocrinol Metab; 2001 Sep; 86(9):4416-23. PubMed ID: 11549685
[TBL] [Abstract][Full Text] [Related]
35. Comparison of steroidogenic pathways among normoandrogenic and hyperandrogenic polycystic ovary syndrome patients and normal cycling women.
Medeiros SF; Barbosa JS; Yamamoto MM
J Obstet Gynaecol Res; 2015 Feb; 41(2):254-63. PubMed ID: 25256274
[TBL] [Abstract][Full Text] [Related]
36. Minireview: regulation of steroidogenesis by electron transfer.
Miller WL
Endocrinology; 2005 Jun; 146(6):2544-50. PubMed ID: 15774560
[TBL] [Abstract][Full Text] [Related]
37. Insulin resistance, polycystic ovary syndrome and metformin.
Pugeat M; Ducluzeau PH
Drugs; 1999; 58 Suppl 1():41-6; discussion 75-82. PubMed ID: 10576524
[TBL] [Abstract][Full Text] [Related]
38. Increased protein expression of LHCG receptor and 17α-hydroxylase/17-20-lyase in human polycystic ovaries.
Comim FV; Teerds K; Hardy K; Franks S
Hum Reprod; 2013 Nov; 28(11):3086-92. PubMed ID: 24014605
[TBL] [Abstract][Full Text] [Related]
39. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.
Hong SH; Sung YA; Hong YS; Jeong K; Chung H; Lee H
Clin Endocrinol (Oxf); 2017 Oct; 87(4):375-380. PubMed ID: 28543550
[TBL] [Abstract][Full Text] [Related]
40. Effects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with polycystic ovary syndrome.
Jakubowicz D; Barnea M; Wainstein J; Froy O
Clin Sci (Lond); 2013 Nov; 125(9):423-32. PubMed ID: 23688334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
